BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1716418)

  • 1. Aprotinin blocks the binding of pro atrial natriuretic peptides 1 to 30, 31 to 67, and 99 to 126 to human placental membranes.
    Vesely DL
    Am J Obstet Gynecol; 1991 Sep; 165(3):567-73. PubMed ID: 1716418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific binding sites for prohormone atrial natriuretic peptides 1-30, 31-67 and 99-126.
    Vesely DL; Cornett LE; MacLeod SL; Nash AA; Norris JS
    Peptides; 1990; 11(2):193-7. PubMed ID: 2162527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific binding site for pro atrial natriuretic factors 1-30, 31-67, and 99-126 on distal nephrons, proximal tubules, renal cortical and medullary membranes.
    Vesely DL; Sallman AL; Bayliss JM
    Ren Physiol Biochem; 1992; 15(1):23-32. PubMed ID: 1372745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrial natriuretic peptide receptors in sheep cotyledons.
    Hatjis CG; Grogan DM
    Am J Obstet Gynecol; 1988 Dec; 159(6):1337-40. PubMed ID: 2849877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneous binding sites for alpha-atrial natriuretic peptide in human umbilical cord and placenta.
    Salas SP; Power RF; Singleton A; Wharton J; Polak JM; Brown J
    Am J Physiol; 1991 Sep; 261(3 Pt 2):R633-8. PubMed ID: 1653541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increase in the plasma levels of the N-terminal and C-terminal portions of the prohormone of atrial natriuretic factor during normal pregnancy.
    Merkouris RW; Miller FC; Catanzarite V; Rigg LA; Quirk JG; Vesely DL
    Am J Obstet Gynecol; 1990 Mar; 162(3):859-64. PubMed ID: 2138415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ozone increases amino- and carboxy-terminal atrial natriuretic factor prohormone peptides in lung, heart, and circulation.
    Vesely DL; Giordano AT; Raska-Emery P; Montgomery MR
    J Biochem Toxicol; 1994 Apr; 9(2):107-12. PubMed ID: 8071945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunocytochemical localization of proANF 1-30, proANF 31-67 and atrial natriuretic factor in the kidney.
    Ramirez G; Saba SR; Dietz JR; Vesely DL
    Kidney Int; 1992 Feb; 41(2):334-41. PubMed ID: 1372667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The action of two natriuretic peptides (atrial natriuretic peptide and brain natriuretic peptide) in the human placental vasculature.
    Holcberg G; Kossenjans W; Brewer A; Miodovnik M; Myatt L
    Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):71-7. PubMed ID: 7847563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atrial natriuretic peptide receptors in guinea pig placentas.
    Hatjis CG; Grogan DM
    Am J Obstet Gynecol; 1989 Aug; 161(2):493-6. PubMed ID: 2548384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kaliuretic peptide: the most potent inhibitor of Na(+)-K+ ATPase of the atrial natriuretic peptides.
    Chiou S; Vesely DL
    Endocrinology; 1995 May; 136(5):2033-9. PubMed ID: 7720651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Negative feedback of atrial natriuretic peptides.
    Vesely DL; Douglass MA; Dietz JR; Giordano AT; McCormick MT; Rodriguez-Paz G; Schocken DD
    J Clin Endocrinol Metab; 1994 May; 78(5):1128-34. PubMed ID: 8175968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrial natriuretic peptide binding in rat placenta, yolk sac, decidua, and maternal placental vessels.
    Scott JN
    Cell Tissue Res; 1993 May; 272(2):391-4. PubMed ID: 8513490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific binding of atrial natriuretic peptide to rat mesenteric artery: effect of calcium and 5-guanylylimidodiphosphate.
    Lyall F; Morton JJ
    Clin Sci (Lond); 1987 Dec; 73(6):573-9. PubMed ID: 2826069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and solubilization of atrial natriuretic factor receptors in human placenta.
    Sen I
    Biochem Biophys Res Commun; 1986 Mar; 135(2):480-6. PubMed ID: 3008723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Respective roles of kallikrein and endopeptidase 24.11 in the metabolic pathway of atrial natriuretic peptide in the rat.
    Vanneste Y; Pauwels S; Lambotte L; Michel A; Dimaline R; Deschodt-Lanckman M
    Biochem J; 1990 Aug; 269(3):801-6. PubMed ID: 1697165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrial natriuretic peptide receptors in normal human placentas.
    Hatjis CG; Grogan DM
    Am J Obstet Gynecol; 1988 Sep; 159(3):587-91. PubMed ID: 2844090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased circulating concentration of the N-terminus of the atrial natriuretic factor prohormone in persons with pheochromocytomas.
    Vesely DL; Arnold WC; Winters CJ; Sallman AL; Rico DM
    J Clin Endocrinol Metab; 1990 Nov; 71(5):1138-46. PubMed ID: 1977756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [N-terminal atrial natriuretic peptides].
    Bełtowski J
    Postepy Hig Med Dosw; 2000; 54(6):895-914. PubMed ID: 11227384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The N-terminal and C-terminal portions of the atrial natriuretic factor prohormone increase during preeclampsia.
    Merkouris RW; Miller FC; Catanzarite V; Quirk JG; Rigg LA; Vesely DL
    Am J Obstet Gynecol; 1991 May; 164(5 Pt 1):1197-202. PubMed ID: 1827948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.